Skip to main content
Công ty Cổ phần Dược phẩm Cửu Long logo

Công ty Cổ phần Dược phẩm Cửu Long — Investor Relations & Filings

Ticker · DCL ISIN · VN000000DCL1 HSX Manufacturing
Open in API
Filings indexed 224 across all filing types
Latest filing 2023-08-22 Regulatory Filings
Country VN Viet Nam
Listing HSX DCL

About Công ty Cổ phần Dược phẩm Cửu Long

http://dcl.com.vn

Cuu Long Pharmaceutical Joint Stock Company (DCL) is a diversified healthcare provider with nearly 50 years of operational history. The company's core activities include the production of pharmaceuticals, medical equipment, and empty hard capsules. DCL is a market leader in empty hard capsules, holding approximately 80% market share. Its pharmaceutical portfolio comprises a range of drugs, chemicals, and medicines. The company serves a broad network of hospitals and medical facilities through an extensive distribution system. DCL is recognized for its commitment to delivering innovative and accessible healthcare products.

Recent filings

Filing Released Lang Actions
DCL: Giải trình chênh lệch lợi nhuận sau thuế bán niên năm 2023 so với cùng kỳ năm 2022
Regulatory Filings Classification · 85% confidence The document is a mandatory regulatory disclosure submitted to the State Securities Commission and the Ho Chi Minh Stock Exchange under Circular 96/2020. It provides a narrative explanation of half-year profit variances without full financial statements or a standalone interim report, and it does not constitute an annual report, earnings release, or audit report. This falls under the general regulatory announcement/fallback category.
2023-08-22 Vietnamese
DCL: Giải trình biến động LNST quý 2/2023 so với cùng kỳ năm trước
Regulatory Filings Classification · 87% confidence The document is a formal disclosure to the State Securities Commission and Ho Chi Minh Stock Exchange explaining the variance in profit after tax for Q2 2023 versus Q2 2022 under Circular 96/2020/TT-BTC. It provides an explanation of individual line-item movements in profit on separate and consolidated financial statements but does not constitute a full interim/quarterly report or earnings release. It is a compliance/ regulatory announcement rather than the report itself, fitting the fallback category for miscellaneous regulatory filings.
2023-07-28 Vietnamese
DCL: Báo cáo tình hình quản trị công ty 6 tháng đầu năm 2023
Governance Information Classification · 90% confidence The document is a detailed semi-annual Report on Corporate Governance (“Báo cáo Tình hình quản trị công ty” for 6 months), covering the board structure, meetings, resolutions, audit committee and governance practices. It does not present financial statements, earnings or management discussion, but focuses exclusively on governance. This fits the Governance Information category.
2023-07-27 Vietnamese
DCL: Nghị quyết HĐQT về việc lựa chọn đơn vị kiểm toán cho năm 2023
Regulatory Filings Classification · 85% confidence The document is an extraordinary 24-hour information disclosure to the State Securities Commission and stock exchange announcing that the Board of Directors has selected an audit firm and signed an audit contract for the half‐year review and full‐year audit. It contains no financial statements or substantive financial data, nor is it publishing or attaching a report itself. It is a general regulatory announcement that does not fit other more specific categories, so it falls under Regulatory Filings (RNS).
2023-07-12 Vietnamese
DCL: Nghị quyết HĐQT số 06/2023 ngày 16/05/2023
Regulatory Filings Classification · 85% confidence The document is an “Extraordinary Information Disclosure in 24 Hours” filed by a Vietnamese listed company, addressed to the State Securities Commission and the Ho Chi Minh Stock Exchange. It announces and attaches a Board of Directors resolution approving contract authorizations and related‐party transactions. It is a regulatory announcement of a board resolution rather than a full annual/interim report, management discussion, or senior management change. Therefore, it falls under general regulatory filings (fallback category).
2023-05-16 Vietnamese
DCL: Giải trình chênh lệch lợi nhuận sau thuế quý 1/2023 so với quý 1/2022
Regulatory Filings Classification · 80% confidence The document is a standalone regulatory disclosure (“Giải trình biến động lợi nhuận sau thuế quý I…”) sent to the State Securities Commission and the Ho Chi Minh Stock Exchange, explaining variances in quarterly profit without presenting any full financial statements. It is not a full interim report, earnings release, or audit, nor board/management changes or any other specific category. As a miscellaneous required disclosure under Vietnamese securities rules, it falls under Regulatory Filings (RNS).
2023-04-26 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.